You are now leaving XTANDI.com
The website you are about to visit is not owned or controlled by Astellas. Astellas are not responsible for the information or services on this site.
NORTHBROOK, Ill., Oct. 27, 2015 /PRNewswire/ -- Astellas recently announced that Doug Geiger has been promoted to the position of vice president, head of New Therapeutic Areas in Marketing Strategy. Geiger will be responsible for delivering global strategic commercial leadership on key initiatives within Astellas' emerging therapeutic areas. He will report to Yukio Matsui, senior vice president and head of Marketing Strategy.
"Doug has been a pivotal strategic commercial leader since joining Astellas in 2008," said Matsui. "He will play an instrumental role as we establish a presence in new therapeutic focus areas such as pain, central nervous system, nephrology and inflammation."
Geiger brings 23 years of experience in the pharmaceutical industry. He joined Astellas in 2008 as director of New Product Planning in the U.S., and helped establish the oncology business unit. Since 2012, Geiger has served as senior director and head of the New Product Planning in the U.S., where he played a vital role in optimizing the commercial potential of Astellas' pipeline.
Prior to Astellas, Geiger held several commercial leadership positions at Abbott Laboratories and TAP Pharmaceuticals in marketing, commercial strategy and global commercial development.
Geiger earned his Bachelor of Science in finance from the University of Illinois, holds a Master of Science in accounting from DePaul University Kellstadt Graduate School of Business and a Masters in Business Administration from Northwestern University Kellogg School of Management.
Astellas is a pharmaceutical company dedicated to improving the health of people around the world through provision of innovative and reliable pharmaceuticals. For more information on Astellas, please visit our website at www.astellas.us, follow us on Twitter at www.twitter.com/AstellasUS or like our Facebook page at www.facebook.com/AstellasUS.
This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.